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ABSTRACT 
Back ground 
Loricrin is a late differentiation protein of terminally differentiated keratinocytes seen 
in the cornified envelope. It is seen in abundance in the keratinizing epithelium, which 
are subjected to considerable mechanical stress. The coarse fibres of areca nut and the 
continuous friction from occluding teeth are the major causes of mechanical stress to 
the oral mucosa in oral submucous fibrosis and hyperkeratosis respectively. This 
study tries to relate the expression of loricrin in these two lesions to the habit of  
chewing  and also its role as a potential marker to diagnose these conditions.. 
Aim and objectives. To evaluate the expression of Loricrin in the epithelium of 
formalin fixed, paraffin embedded tissue specimens of oral submucous fibrosis, 
hyperkeratosis  and  normal mucosa by immuno histochemistry. 
Materials and methods. Archival samples of tissue specimens (n=73), which were 
formalin fixed and paraffin embedded were stained with antibodies to loricrin and the 
intensity of staining was graded as (-) negative, (+) mild,(++)moderate and (+++) 
intense. Pearson’s chi square test was done for statistical analysis.   
Results and Conclusion. Loricrin expression was observed in all the groups with  
prominent staining in the stratum granulosum and had a significant association to 
habits.(P=0.000).The prominent staining indicates a compensatory mechanism in the 
surface of the epithelium in the early stages of oral submucous fibrosis and has the 
potential to be  an early marker  of  the condition.  
Key words - Loricrin, OSF, Areca nut  Hyperkeratosis. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Introduction 
 
 Oral carcinoma is one of the most common cancers in India and proceeds 
through a stepwise accumulation of genetic damage over time
1
. The oral cavity is 
easy to examine and there is a great opportunity to improve patient outcomes 
through diagnosis and treatment of oral potentially malignant disorders before the 
development of invasive oral carcinoma. Developments in detection and diagnosis 
of oral potentially malignant lesions and innovative approaches in  management of 
early oral neoplasia by means of technological and therapeutic advances are much 
needed to improve the poor outcomes associated with oral cancer. Genetic 
mutations often produce early phenotypic changes that may present as clinically 
apparent, recognizable lesions. Clinical presentations of the oral cavity that are 
recognized as potentially malignant were classified into two broad groups, taking 
into account the diverse clinical appearances presented world wide as lesions and 
conditions.
1
 
 A potentially malignant lesion is a morphologically altered tissue in 
which oral cancer is more likely to occur than in its apparently normal counterpart 
or a generalized state associated with a significantly increased risk of Cancer. This 
was proposed by an earlier working group of the world health organization (WHO) 
in 1978. 
2
  
The histological finding of epithelial dysplasia is strongly associated with 
an increased rate of invasive cancer development. Some molecular biomarkers 
with potential diagnostic relevance include DNA content and chromosome 
polysomy, loss of heterozygosity (LOH), nucleolar organizer regions, histo-blood 
group antigens, proliferation markers such as Ki-67, increased Epidermal growth 
factor receptor (EGFR), and decreased expression of p16, and p53. Although a 
reliable, validated marker panel for providing clinically useful prognostic 
information in OPL patients has not yet been established, the advent of genomic 
and proteomic analysis techniques may soon yield major advances toward a 
prognostically relevant molecular classification system 
2,3
 
Certain proteins can act as potential markers in determining the various 
stages of these potential malignant disorders and will serve as a valuable tool in 
providing a better outcome in both prognosis and treatment to the patient, one such 
marker could be Loricrin, which is a major protein  of  the cornified envelope of 
human epidermis, and is one of the differentiation markers of terminally 
differentiated keratinocytes. Its abundant  presence in keratinizing epithelium, 
subjected to considerable mechanical stress has led to the assumption that 
expression of Loricrin is essential for the function of these tissues.  
Oral submucous fibrosis is a chronic insidious disease affecting any part of 
the oral cavity and sometimes the pharynx, Occasionally preceded by and/or 
associated with vesicle formation and is always associated with a juxta-epithelial 
inflammatory reaction followed by progressive hyalinization of the lamina 
propria.
4
 
 This lesion represents 80% of potentially malignant oral lesions and is 
defined as a white patch or plaque that cannot be characterized clinically or 
pathologically as any other disease and is not associated with any physical or 
chemical causative agent except the use of tobacco. This is a diagnosis by 
exclusion for a lesion that cannot be given another specific diagnostic name and 
does not typically disappear with removal of known aetiological factors, excepting 
smoked tobacco.
5 
 Analysis using the microarray technique of the expression 
profiles of 8,800 genes in human oral leukoplakia (n=4) and oral squamous cell 
carcinoma (OSCC) (n=2) was done to identify the genes responsible for its 
pathogenesis and malignant transformation. Eight genes were up-regulated (>2.0-
fold) and ten were down-regulated (<0.5-fold) in all leukoplakia samples. Loricrin 
and keratins displayed greater differences between normal tissue and leukoplakia  
suggesting  that gene abnormalities in cytoskeleton network components might be 
responsible for the development and progression of oral leukoplakia.
6,7
 
This study is undertaken to demonstrate expression of loricrin (a key factor 
in maintaining the barrier function of the epidermis in keratinising epithelia), in 
non keratinising epithelia of oral mucosa  attributing its presence to the mechanical 
stress induced by the chewing habits of areca nut in conditions like OSF and 
hyperkeratosis ,where its presence kicks in as a  protective compensatory 
mechanism. The expression of this unique protein has been analysed in certain 
conditions with hyperkeratosis like frictional keratosis and epithelial dysplasia and 
oral submucous fibrosis (OSF)  in this study 
   
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                               Aims and Objectives 
 
AIM:  
To evaluate the expression of Loricrin in the epithelium of Oral submucous 
fibrosis and hyperkeratosis and normal mucosa.  
 
OBJECTIVES: 
 
 To study the expression of loricrin in formalin fixed paraffin embedded 
tissue specimens of oral submucous fibrosis by immuno histochemistry. 
 To study the expression of loricrin in formalin fixed paraffin embedded 
tissue specimens of hyperkeratosis by immuno histochemistry. 
 To study the expression of loricrin in formalin fixed paraffin embedded 
tissue specimens of normal mucosa by immuno histochemistry. 
 To compare the expression of loricrin in formalin fixed paraffin embedded 
tissue specimens of Oral submucous fibrosis, hyperkeratosis and normal 
mucosa by immuno histochemistry. 
 
HYPOTHESIS: (NULL) 
There is no difference in the expression of Loricrin in the epithelium of oral 
submucous fibrosis, hyperkeratosis and  normal mucosa. 
 
 
 
HYPOTHESIS (ALTERNATE)  
 
There is a difference in the expression of Loricrin in the epithelium of oral 
submucous fibrosis, hyperkeratosis and normal mucosa. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
            Materials and Methods   
STUDY SETTING  
 
The study was conducted in the Department of Oral and Maxillofacial Pathology, 
Ragas Dental College and Hospital, Chennai, using formalin fixed paraffin 
embedded tissues.  
 
It was a retrospective study, done to evaluate the expression of loricrin  in 
oral submucous fibrosis, hyperkeratosis and normal mucosa using 
immunohistochemistry in archival formalin fixed, paraffin embedded tissue 
specimens. The study was approved by the Institutional Review Board. (Annexure 
I) and a protocol was submitted for the same. (Annexure II) Informed consent was 
obtained from patients for samples of normal buccal mucosa for the control group. 
 
 
STUDY SAMPLE SIZE 
 
The study material comprised of 73 formalin fixed, paraffin embedded tissue 
specimens (archival blocks).  
Sample size calculation-The above sample size was calculated for  a power of 
80% at 5% significance level. 
 
 
       
 
    STUDY SUBJECTS (n=73)  
 
            The study comprised of 3 groups  
 
   Group I (n=11) 
Eleven archival blocks of clinically normal buccal mucosa, obtained from 
patients reporting to the outpatient department of oral and maxillofacial 
surgery for elective removal of impacted third molar constituted group I. 
 
Group II (n=32) 
Thirty two archival blocks of histopathologically confirmed hyperkeratosis 
tissue specimens. (Both frictional keratosis and epithelial dysplastic lesions 
with hyperkeratosis were included within this group) 
 
Group III (n=30) 
Thirty archival blocks of histopathologically confirmed oral submucous 
fibrosis tissue specimens.  
 
 
 
 
 
 
METHODOLOGY 
 
1.  Tissue samples of oral submucous fibrosis (n=30),hyperkeratosis (n=32)  
and normal mucosa (n=11) were drawn  from the  archives of  department 
of oral and maxillofacial pathology. 
2.  Four micron thick sections were cut and used for routine Haematoxylin and 
Eosin   (H & E)  staining 
3.  H & E  staining and immunohistochemical (IHC) staining was performed. 
4.  This project was approved by The Institutional Review Board (IRB) of 
Ragas Dental  College and Hospital, Chennai and patient consent was 
taken. 
           All materials were procured from MERCK
TM 
and were of analytical grade 
unless mentioned. 
 
 
HAEMATOXYLIN & EOSIN STAINING 
REAGENTS 
 Harris’s haematoxylin 
 1% acid alcohol 
 Eosin 
 
PROCEDURE  
 The slides were dewaxed in xylene and hydrated through graded 
alcohol to water.  
 The sections on the slides were flooded with Harris’s haematoxylin  for 
5 minutes.  
 The slides were washed in running tap water for 5 minutes.  
 The slides were differentiated in 1% acid alcohol for 5 minutes. 
 The slides were washed well in running tap water for 5 minutes.  
 The tissue sections on the slides were then stained in eosin for 30 
seconds.  
 The slides were washed in running tap water for 1 minute.  
 The slides were then dehydrated through alcohol, cleared, mounted and 
viewed under light microscope (LM). 
IMMUNOHISTOCHEMISTRY (IHC) 
ARMAMENTARIUM  
 Microtome  
 Autoclave 
 Hot air oven 
 Slide warmer 
 Couplin jars 
 Measuring jar 
 Weighing machine 
 APES coated slides 
 Slide carrier 
 Aluminum foil 
 Micro-pipettes 
 Toothed forceps 
 Electronic timer 
 Beakers 
 Rectangular steel tray with glass rods 
 Sterile gauze 
 Cover-slips  
 Light microscope 
 
REAGENTS USED 
1) Concentrated  Hydrochloric acid, Analytical grade 
2) Laxbro solution. 
3) APES (3 amino propyl tri ethoxy silane) 
4) Acetone  
5) Citrate buffer 
6) Phosphate  Buffer Saline (PBS) 
7) 3% Hydrogen peroxide (H2O2) 
8) Deionised distilled water 
9) Absolute alcohol 
10) Xylene 
 
 
ANTIBODIES  USED 
1. Primary antibody –   Loricrin polyclonal antibody, Abcam, Allied scientific  was 
used in a concentrated form. 
2. Secondary antibody –Expose  Mouse and Rabbit specific HRP/DAB  detection 
IHC  kit containing Poly Horse Radish Peroxidase –pre titrated anti-species 
immunoglobulin  labeled with enzyme polymer (Goat anti rabbit HRP conjugate) 
and mouse specifying reagent, and liquid  DAB- Diamino-benzidine-chromogen . 
IHC PROCEDURE 
PRETREATMENT OF THE SLIDES  
 The slides were first washed in tap water for few minutes  
 The slides were then soaked in detergent solution for 1 hour 
 After 1 hour, each slide was brushed individually using the detergent 
solution and were transferred to distilled water.  
 The slides were washed in two changes of distilled water 
 The slides were washed in autoclaved distilled water 
 The slides were immersed in 1 N hydrochloric acid (HCL) (100 ml HCl in 
900 ml distilled water) overnight 
 The following day, slides were taken out of acid and washed in two 
changes of autoclaved distilled water 
 All the slides were then transferred to slide trays, wrapped in aluminium 
foil and baked in hot air oven for 4 hours at 180 degrees centigrade. 
APES (3 Amino propyl tri ethoxysilane) coating 
Slides first dipped in couplin jar containing acetone for 2 minutes 
 
Dipped in APES for 5 minutes 
 
Dipped in two changes of distilled water for 2 minutes each 
 
Slides left to dry 
PREPARATION OF PARAFFIN SECTIONS 
After the slides were dry, tissue section of 5 micron thickness were made in a 
rotary microtome. The ribbons of tissue section were transferred onto the APES 
coated slide from the tissue float bath such that two tissue bits come on to the slide 
with a gap in between. One of the tissue sections was labelled positive (P) and the 
other negative (N). 
 
 
 
 
PROCEDURE 
The slides with tissue sections were treated with three changes of xylene to remove 
paraffin wax. They were put in descending grades of alcohol and then rehydrated 
with water. The slides were then transferred to citrate buffer with a pH of 6.0 and 
autoclaved for antigen retrieval at 15 lbs pressure for 30 minutes. The slides were 
dipped in 3 changes of phosphate buffered saline for 5 minutes each. Circles were 
drawn around the tissues, so that the antibodies added later on do not spread and 
are restricted to the circle. Slides were then treated with 3% hydrogen peroxide for 
15 minutes to quench endogenous peroxidase activity of cells that would otherwise 
result in non-specific staining. The tissues were incubated in protein blocking 
serum for 10 minutes in an enclosed hydrated container. Then the slides were 
wiped carefully without touching the tissue section to remove excess of blocking 
serum. The primary antibody, Loricrin polyclonal antibody was added to P tissue 
on the slide while PBS was added to the N tissue on the slide. The slides were 
incubated for one hour. Then the slides were wiped carefully without touching the 
tissue section to remove excess of antibody and washed with three changes of cold 
PBS for 5 minutes. A drop of Mouse specifying reagent was added to both sections 
on the slide and allowed to stand for 15 minutes and was followed by PBS buffer 
rinse two times. Then a drop of Goat anti rabbit specific HRP conjugate is added to 
both sections  and allowed to stand for 10 minutes. (Expose Mouse & Rabbit 
specific HRP/DAB detection kit:Ab80436-15ml) 
 Later slides were rinsed 4 times in PBS. The slides were wiped carefully without 
touching the tissue section to remove excess PBS. Then a drop of DAB was added 
to the sections. Slides were then rinsed  in PBS to remove excess chromogen and 
counter stained with hematoxylin for 30 seconds . The tissue sections were 
mounted with DPX. The slides were then observed under the microscope. 
Throughout the procedure care was taken not to dry the tissues. 
Positive Control: A foreskin specimen procured after circumcision  for  Phymosis  
was fixed, processed, embedded, sectioned and stained in the same manner and 
used as positive control. One positive control tissue slide was included for each 
batch of staining. 
IHC PROCEDURE FLOW CHART 
APES coated slides with 2 paraffin embedded tissues 
 
Placed in xylene twice (5 minutes each) 
 
Placed in 100%  isopropanol  (5 minutes) 
 
Placed in 70%  isopropanol    (5 minutes) 
 
Washed in distilled water (5 minutes) 
 
Kept in citrate buffer at pH 6 and autoclaved for antigen retrieval and bench cooled 
for 40 minutes 
 
Washed in PBS thrice (5 minutes) 
 
Placed in 3% hydrogen peroxide (15 minutes) 
 
Protein blocking serum added and incubated for 10 minutes 
 
Primary antibody added to the specimen and incubated for one hour 
 
Washed in PBS thrice (5 minutes each) 
 
Secondary antibody added and incubated in an enclosed hydrated container (15 
minutes) 
 
Rinsed in PBS twice 
 
HRP -Goat anti rabbit specifying reagent added and   incubated (15 minutes) 
 Rinsed in PBS four times 
 
DAB added and incubated in an enclosed hydrated container (5 minutes) 
 
Rinsed in PBS four times 
 
Counterstained with hematoxylin(30 seconds) 
 
Rinsed in tap water 
 
Slides were mounted using DPX 
 
Slides were observed under the Light Microscope and graded 
 
Criteria for evaluation of Loricrin staining 
The parameters used to evaluate Loricrin (LOR) staining were as follows 
1. Tissue localization of stain –Loricrin staining is localized to the 
epithelium. 
Seen in the stratum granulosum and stratum corneum of stratified 
squamous epithelium in keratinized epithelia, while it is absent in non 
keratinising epithelium of the oral mucosa. 
2. Cellular localization of stain –The Stain is localized to both the cytoplasm 
and Nucleoplasm of the cells. 
 
3. Degree of positivity –Each case was graded as (-)  nil or absence of stain, 
(+) mild,  (++)  moderate    and    (+++)  intensively  stained  based on the 
intensity of staining taken up by the tissue as observed by three blinded 
observers independently. 
4. Statistical analysis-Data were entered and analyzed using SPSS TM 
software (version 17.0). Pearson’s Chi-square test was done to compare 
intensity of staining between the groups and a P value <0.05 was 
considered statistically significant. Kappa analysis was done to compare the 
intensity of loricrin staining as observed between three observers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                              
                                            Review of Literature 
 
 
  
 Epithelial tissues are the main appendages that protect the body’s internal 
tissues from the environmental stresses, chemical damage and bacterial infection. 
The stratified epithelia of the skin and oral mucosa are examples of the toughest 
and most protective epithelia.
8
 Keratinizing epithelia such as the epidermis and 
oral gingiva that have to withstand severe physical and chemical forces produce a 
toughened structure, the cornified cell envelope. The stresses or insults have been 
implicated as a causative factor in the progression from a potentially malignant 
disorder to a condition of full blown cancer.
9
 
  The coarse fibres of areca nut and the continuous friction from occluding 
teeth are the major causes of mechanical stress to the oral mucosa in oral 
submucous fibrosis and frictional keratosis (hyperkeratosis) respectively. Hence, 
the role of Loricrin in oral epithelium needs to be studied in these two lesions 
which when identified, serves as a early diagnostic marker in identifying the 
potentially malignant disorders, thereby leading to a better prognosis and better 
treatment option for the patient at risk from oral cancer.  
 
Oral submucous fibrosis (OSF) 
Submucous fibrosis may be defined as an insidious, chronic disease 
affecting any part of the oral cavity and sometimes the pharynx. Although 
occasionally preceded by and/or associated with vesicle formation, it, is always 
associated with juxtaepithelial inflammatory reaction followed by a fibro elastic 
change of the lamina propria, with epithelial atrophy leading to stiffness of the oral 
mucosa and causing trismus and inability to eat.
10
 
In 1952, Schwartz  described five Indian women from Kenya with a condition of 
the oral mucosa including the palate and pillars of the fauces, which he called 
"Atrophia idiopathica (tropica) mucosae oris". Later it was termed oral submucous 
fibrosis(OSF) by Joshi in 1953.
11
 
The other names for this condition are "diffuse oral submucous fibrosis", 
"idiopathic scleroderma of the mouth", "idiopathic palatal fibrosis", "sclerosing 
Stomatitis" and "juxtaepithelial fibrosis"
10 
 
Geographical distribution and Epidemiology  
Worldwide estimates in 1996 indicate that 2.5 million people were affected 
by this disease. In 2002, the statistics for OSF from the Indian continent alone was 
about 5 million people (0.5% of the population of India)   
Cases have also been reported in other parts of the world among Indian 
settlers or people of ethnic origin. Potential for malignant transformation into 
squamous cell carcinoma has been observed in one third of the cases with 
submucous fibrosis in a clinical study with 650 patients in India.
12
 Another study 
on oral cancer and precancerous lesions in a rural Indian
 
population revealed  the 
malignant transformation rate of OSF to be 7.6% (5 of 66) over a 17-year period 
(median observation, 10 years)
13 
Women seemed to show a higher prevalence that seems to be related to the 
deficiency of iron and vitamin B complex seen among many Indian women
12
  
The prevalence of oral submucous fibrosis, leukoplakia, and oral lichen planus 
were 0.55%, 0.59% and 0.15% respectively in a cross sectional study conducted 
among 2017 consecutive patients  from sub urban and rural areas of Chennai 
Tamilnadu during a period of three months with their prevalence directly 
proportional to their habits of chewing and smoking.
12
 A case control study in 
Taiwan with a study group of 35 cases and 100 controls showed a high correlation 
between this condition and areca nut chewing.
 14
 According  to J.J .Pindborg, the 
greater  prevalence in the Indian sub continent is related to its ethnical use of areca 
nut products. A wide range in the age of patient are seen with the majority in the 
20-40 age group. with a higher prevalence among the south Indians than  north 
Indians.
10
  
Aetiology of OSF: 
The cause of the OSF, is still obscure with the various hypotheses put 
forward, pointing to a multifactorial origin. Hypersensitivity to chilli and betel nuts 
and nutritional deficiencies have all been suggested at various times to account for 
the pathogenesis of the disease, with emphasis on locally acting irritants on the oral 
mucosa.
 15 
Capsaicin of chillies has been associated in the pathogenesis of OSF in 
some studies while no evidence for the same has been proposed by Hamner et al  
in experiments with hamster cheek pouch.
16,17
 Short term experimental tests  on 
experimental animals with chilli extracts  has been found to be mutagenic, 
enhancing  the tumorigenicity of tobacco  products. Increased chilli consumption 
has also been shown to increase the risk of cancers in the upper digestive tract in a 
dose dependent manner 
10
 However no association between chilli and OSF was 
found in a Taiwanese study of 35 cases with 100 controls.
14
 
OSF is frequently associated with nutritional deficiency  which is usually  
secondary to the condition.
17
An increased mucosal susceptibility to irritants like 
areca nut and chillies are seen in deficiencies of vitamin and iron which  leads to 
derangement in the inflammatory reparative response in the lamina propria with 
resultant defective healing and scarifications
18
. Genetic susceptibility for this 
condition  is  implicated  to the action of extrageneous factors like tannins and 
areca alkaloids and in conditions where there are no habits of areca nut chewing. 
An autoimmune explanation could also be given to OSF due to its similar 
appearance to other disorders like scleroderma in both its clinical presentation and 
its histologic characteristics.
19
 Canniff et al has reported an increase in the DR3 
antigens in OSF along with serum immunoglobulin and auto antibodies similar to 
an increase in the DR gene seen in scleroderma.
20,21 
Areca nut chewing  plays a major role in the aetiology of OSF,  and has 
been said to play a role in the pathogenesis, by stimulation of the fibroblast by its 
constituents notably the alkaloids  resulting in phenotype alteration and increased 
collagenesis, which could be  seen in tissue culture studies involving cell lines 
from human fibroblasts which have reproduced  connective tissue disorders as they 
maintain their phenotype in culture and their properties in vivo. Fibroblasts 
metabolize the alkaloid arecoline to arecaidine and its esters which  in turn acts as 
a stimulator of the proliferation of fibroblasts and collagen synthesis. The relative 
risk of OSF, increased with the duration as well as the frequency of the  areca nut 
(main ingredient in Mawa) chewing habit.
15
 
The severity and the time taken for the development of the disease may also 
vary according to the preparation of areca nut consumed. The commercially freeze 
dried products such as pan masala, gutka and mawa (areca and  lime) have high 
concentrates of areca nut per chew and appear to cause OSF more rapidly than by 
self prepared conventional betel quid which contain smaller amounts of areca 
nut.
22
 
Clinical presentation in oral submucous fibrosis. 
Oral submucous fibrosis  has an insidious onset of about 2 to 5 years 
presenting  with prodromal symptoms which include ,appearance of  blisters  
especially in the palate, burning sensation  on consuming spicy foods, ulcerations, 
recurrent generalized  inflammation of the oral mucosa, defective gustatory 
sensation  and dryness of the mouth, with  periods of waning  and exacerbations 
varying from 3 months to 1 year.
4
  
Focal  vascular manifestations in early OSF present clinically as petechiae, in the 
absence of any other blood dyscrasias  might be  a hypersensitive reaction of the 
oral mucosa in response to an external stimulant like areca nut and  chillies 
revealing a slightly atrophic epithelium with numerous dilated and blood filled 
capillaries seen juxtaepithelially.
20 
 
The major presenting complaint is a progressive inability to open the mouth 
because of the accumulation of inelastic fibrous tissue in the juxtaepithelial region 
of the oral mucosa, along with concomitant muscle degeneration A study which 
enabled assessment of alterations in oral submucous fibrosis by establishing  the 
parameters of normal mouth opening (mo), tongue protrusion (tp) and cheek 
flexibility (cf) was done to determine early changes was done by Ranganathan et 
al
23
 
 
 
 
Histological Features in oral submucous fibrosis. 
Histologically, OSF is characterized by juxtaepithelial fibrosis, along with 
atrophy or hyperplasia of the overlying epithelium, keratinizing metaplasia, and 
accumulation of hyalinised collagen beneath the basement membrane with a 
progressive loss of vascularity. Often, a variable infiltration of the lamina propria 
with chronic inflammatory cells also is evident. (Utsunomiya et al)
24
 
 
Changes observed  in the epithelium of oral submucous fibrosis. 
OSF shows ultra structural changes at both the light microscopic and 
electron microscopic level. Variations can be seen depending on the site of the 
lesion and the severity of the condition observed clinically.OSF is a connective 
tissue disorder and the changes seen in the epithelium are  only secondary to the 
connective tissue changes. The epithelium is dependent on the connective tissue 
for its nutrients and  shows a varied presentation with a normal appearance to a 
atrophied or a hyper plastic one. 
20
 
Hyper plasticity  could be due to an protective response to the local irritants 
Atrophic epithelium with loss of reteridges is seen in a majority  of the cases when  
compared with normal mucosa. Intracellular oedema, signet cells with focal areas 
of dysplasia is seen frequently. Keratinisation  tends to be higher in atrophic or 
hyper plastic epithelium along with  vacuolization of the prickle cell layer  and   
increased  mitosis. An increase in the intercellular spaces leads to a  greater 
permeability to water and other serum derived antibodies as well as to local 
irritants.  
The haematoxylin and eosin stained sections are helpful in characterizing the 
changes that are observable within the connective tissue and have four consecutive 
stages namely the presence  or the absence of oedema, state of the blood vessels 
Nature of the collagen bundles,  the overall fibroblastic responses  along with the 
predominant inflammatory cell infiltrate.
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EM  changes in the epithelium of oral submucous fibrosis: 
  In the epithelium the small red pin sized areas seen  with the naked eye are 
suggested to be areas with complete loss of epithelium focally, while ultra 
structurally there is reduction in the number of cell layers in association with 
intracellular oedema. This oedema in turn causes loosened inter digitations and 
widened intercellular space with the cell organelles with reduced  or absent 
tonofilaments .The cells  therefore appear darker with shrunken cytoplasm  
pyknotic nuclei and  marginated chromatin.
24,25 
SEM  changes in the epithelium : 
Scanning electron microscopy( SEM) reveals  obliteration of the elevated 
ridges of the cell boundaries without alteration seen in the micro rugae. Some areas 
showed  desquamation of the squamous epithelial cells along with complete focal 
loss of the covering epithelium ,resulting  in exposure of the sub epithelial 
connective tissue. The  SEM also showed the presence of  microbes on the 
epithelial cell surface which  was an significant find as the invasion of the 
microbes  subepithelially would lead to an altered oral homeostasis with resultant 
proliferation of the microbes enhancing the importance of the disruption of the oral 
barrier.
26 
 
 Haque et al in a study investigated the presence and distribution of 
inflammatory cells and MHC class II antigen expression by epithelial and 
immunocompetent cells using a three-stage immunoperoxidase method on frozen 
sections of thirty OSF sections. The cell population detected in OSF showed higher 
numbers of CD3 and HLA-DR-positive cells in the basal layer of the epithelium, 
juxtaepithelium and in the lamina propria in a similar distribution to that of CD3 
cells compared with the normal tissues. The increased evidence of CD4 and HLA-
DR-positive cells in OSF tissues suggests that most lymphocytes were activated 
and shows an increased presence of Langerhans cells. The presence of these 
immunocompetent cells and high ratio of CD4 to CD8 in OSF tissues suggest an 
ongoing cellular immune response leading to a possible imbalance of 
immunoregulation and  alteration in local tissue architecture.
27
 
 
The electron microscopic study in 11 OSF cases  revealed densely packed 
collagen bundles in the lamina propria seen close to the epithelial connective tissue  
junction with thinner type III collagen fibrils present here along with a variation of 
type I fibrils  which form the bulk of the fibrils. Inspite of their increased density 
,they were found to be morphologically normal. This is also confirmed by 
polarization and special staining with Sirius red.
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Treatment of OSF: 
Though many treatment protocols for oral submucous fibrosis have been 
proposed, there are few if any controlled studies evaluating the effectiveness of 
treatment protocols Treatment strategies that have been tried, are topical & 
systemic steroids supplements of vitamins, minerals & micronutrients, use of 
enzymes, repeated dilatations with physical devices & surgery. Local & systemic 
application of glucocorticoids, placental extracts & immunomodulators are most 
commonly used as they suppress the inflammatory reaction, decrease collagen 
formation. In severe cases, surgical intervention is the only treatment modality, but 
relapse is a major problem.
28
 Inspite of the various treatment options available the 
best way to stop progression  is cessation of habits and identification of the disease 
condition by its association with the habit of areca nut and betel quid chewing, 
Immunohistochemical evaluation at an early stage acts as an valuable adjuvant  
and  helps in identification of the stage of the disease and helps us to provide 
treatment which would provide a better treatment prognosis.     
 
Association of areca nut and OSF and micro trauma  
The IARC Monographs (2004) found that there is a relationship between 
the use of areca nut extract and development of OSF, prompting the World Health 
Organization to classify areca nut as a group I carcinogen.  
Areca nut is consumed in various forms with and without tobacco such as betel 
quid (areca nut + slaked lime + betel leaf), pan masala (powdered areca nut with 
additives + flavouring agents + tobacco) and raw areca nut (seeval flakes and kotta 
paaku granules). In India, there are regional variations in the type of areca nut 
product used 
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Paymaster in a clinical study of 650 cases in Indian patients reported  
malnutrition with subsequent avitaminosis and long-continued chewing of betel 
nut  with  tobacco as predisposing factors to oral cancer.
11
 
  A case control study done by Ranganathan et al in south India with a 
study group of 185 patients with a  male to female ratio of OSF cases was 9.9:10. 
Indicate that OSF is significantly associated with use of pan masala and pan masala 
plus areca nut, with or without concurrent alcohol use, with the risk being greatest 
for pan masala (processed areca nut without betel leaf; odds ratio, 81.5). Followed 
by areca nut plus alcohol use (odds ratio, 69.9).  Tobacco smoking and use of 
alcohol without use of areca nut products is not associated with OSF and are not 
risk factors for OSF alone or in combination.
29
OSF is a clinically significant 
disorder characterized by fibrosis of the sub mucosal tissues of the mouth, which 
limits movement of the oral mucosae and tongue, giving rise to microstomia and 
eventual dysarthria and dysphasia, with a  significant risk of potentially-malignant 
and malignant disease  predominantly caused by both  long-term use of areca nut-
containing agents and  a genetic basis.
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A study by Chang et al showed that areca nut and Arecoline in betel quid  
may inhibit the growth of oral mucosal fibroblasts (OMF) and keratinocytes 
showed that areca nut extract (100-800 microgram/ml) and arecoline (20-120 
micro mol) inhibited the growth of oral KB cells (a subtype of cultured cancer cell 
line) by 36-90%  and 15-75%, respectively, indicating  that areca nut  ingredients 
are crucial in the pathogenesis of  OSF and oral cancer by differentially inducing 
the dysregulation of cell cycle control, Glutathione (GSH) level and intracellular 
hydrogen peroxide (H2O2) production, these events being not coupled with cellular 
changes.
30   
Both areca nut and betel quid act as irritants to the oral mucosa, 
mechanically and chemically. Arecoline, the most abundant alkaloid undergoes 
nitrosation giving rise to N-nitrosamines, which has a cytotoxic effect on cells, at 
the same time promoting synthesis of collagen. 
 The constant contact between the mixture and oral mucosa which  occurs due to 
the habit of placing the betel quid in the buccal vestibule for about 15 min to an 
hour with the action being repeated five to six times a day, depending upon the 
individual’s chewing habit, leads to absorption and metabolization of the  alkaloids 
and flavonoids in the betel quid which acts betel quid constituents and their 
metabolites, the coarse fibres of areca nut also cause mechanical irritation to the 
oral mucosa.
15
 
The micro trauma produced by the friction of coarse fibres of areca nut also 
facilitates the diffusion of betel quid alkaloids and flavonoids into the sub-
epithelial connective tissue, resulting in juxtaepithelial inflammatory cell 
infiltration, which turns into a chronic inflammatory cell infiltrate due to the 
persistent habit. Atrophy and ulceration of the mucosa follow the initial irritation. 
Inflammation is characterized by the presence of activated T cells, macrophages, 
with elaboration of various chemical mediators of inflammation like prostaglandins 
(PGs) whose secretion by oral keratinocytes in response to areca nut extract has 
been shown .Aberrant and persistent tissue inflammation are  crucial for the 
occurrence of cancer and tissue fibrosis. Thus, it can be considered that induction 
of oral mucosal inflammation by betel quid ingredients to be a critical event in the 
pathogenesis of OSF. Cytokines like interleukin 6, Tumour necrosis factor (TNF), 
interferon alpha and growth factors like TGF-b and FGF are synthesized at the site 
of inflammation.
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Fibroblast growth factor (FGF) also act as mitogens for endothelial cells 
and other fibroblast like cells and are involved in angiogenesis, directing 
endothelial cell migration, proliferation and plasminogen activator synthesis. Both 
activated macrophages and damaged endothelial cells produce FGF2 which is also 
a mitogen for keratinocytes indicating a role in skin wound healing with in vivo 
experiments showing an acceleration in granulation tissue formation fibroblast  
proliferation  and  collagen  accumulation, with  enhancement  of  vascularisation 
and  re-epithelialisation.
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Fibrosis of a reparative type usually develops after an initial insult which 
leads to cellular injury, as might be the case in OSF following mechanical insult by 
the coarse fibres of areca nut or pulmonary fibrosis following asbestos exposure, 
with its pathophysiology following a parallel path with wound healing and tissue 
repair. Excessive matrix deposition not triggered by tissue injury but by a direct 
stimulation from local factors also results in fibrosis, like interstitial and 
perivascular fibrosis in heart compromising function. 
Therefore, the fibrotic response appears to be determined by three factors: 
 (1) A continuous insult or stimulus, suggesting that the fibrotic process is an on-
going event;  
 (2) Excessive synthesis of collagen and other extra cellular matrix (ECM) 
components; and 
 (3) Decrease in the resolution owing to down regulation of the degradative 
enzymes involved in removing the scar tissue.  At present, it is not clear if factors 
such as genetic predisposition are important in determining the susceptibility to 
developing these conditions
31 
Increased susceptibility among individuals who are anaemic due to iron or 
vitamin B12 deficiencies has been demonstrated. This could be due to increased 
fragility of the mucosa by which there is more betel quid absorption.  
TGF-β1 is a key regulator of ECM assembly and remodelling. The action 
of TGF-β on the genes implicated in the formation and degradation of the ECM is 
mostly exerted at the transcriptional level through ill defined intracellular 
pathways. The molecular events usually follow the collagen production pathway 
and collagen degradation pathway, as regulated by TGF-β and the flavonoids 
present in areca nut.
 
The risk for oral leukoplakia also increased with the level of 
intensity, suggesting a dose–response relationship between areca-nut chewing and 
oral leukoplakia
15
.
 
 
Cornified cell envelope (CE) 
The Cornified cell envelope CE is a 15nm thick layer of insoluble protein,
34
 
which is seen as an electron dense band on the inner side of the plasma membrane 
of keratinocytes during terminal differentiation. It first appears in the most 
superficial granular or transitional cells of terminally differentiating stratified 
squamous epithelia and  is composed of a 10-nm-thick layer of a cross-linked 
sheath of proteins and a 5-nm-thick layer of ceramide lipids that is covalently 
attached to the proteins. Various proteins, which are mostly transglutaminase 
(TGase) substrates, are included in the CE. 
32,33
 
 
 
 
Factors influencing CE formation 
Diverse environmental stimuli like contact allergens and ultraviolet light 
trigger a cutaneous inflammatory response by directly inducing 
epidermal keratinocytes to elaborate specific pro-inflammatory cytokines and 
adhesion molecules leading to activation of dermal microvasculature endothelial 
cells and selective accumulation of specific mononuclear  cells in the dermis and 
epidermis, indicating that keratinocytes may act as a “signal transducer” capable of  
converting exogenous stimuli into the production of cytokines, adhesion 
molecules, and chemo tactic factors (acting in an autocrine and paracrine fashion) 
responsible for initiation of "antigen-independent" cutaneous inflammation.
34
 
This initiation phase facilitates production of tumour necrosis factor–alpha 
and interferon gamma by the antigen dependent pathway keratinocyte/T 
cell/antigen-presenting dendritic cellular associations. The direct activation 
of keratinocytes, with their ability to produce the complete repertoire of pro-
inflammatory cytokines, can profoundly influence endogenous and recruited 
immunocompetent cells, thereby providing the critical trigger responsible for the 
swift and clinically dramatic alterations that occur following contact between the 
epidermis and a host of "noxious" agents.
34
  
Skin functions as a stable, physical and chemical barrier from 
environmental influences. The CE is a critical structure for barrier function at the 
outermost layer of the skin epidermis. For the formation of CE in terminal 
keratinocyte differentiation, covalent cross-linking of constituting proteins such as 
involucrin, loricrin, small proline-rich protein is essential and requires the calcium 
dependent enzyme transglutaminase (TGase) for  catalyzing the isodipeptide bond 
formation. 
Among proteins TGases 1,3 and 5 participate in CE formation . TGases 1 and 3 are 
activated by limited proteolysis  during differentiation of the keratinocytes  and 
this contributes  to the sequential cross-linking of substrates, utilizing different 
glutamine and lysine residues, indicating that both enzymes have distinctly 
complementary and essential functions in the utilization of loricrin for CE 
assembly in vivo 
35
  therefore disorders of TGases leads to irregular phenotype in 
the skin.
33
  Loricrin contains three glycine rich domains which are thought to form 
uniquely flexible glycine loops, interspersed by glutamine-rich motifs and flanked 
by lysine- and glutamine-rich amino and carboxy terminal domains  
36,37
 
An evolutionary analysis of Keratinisation in association with CE formation. 
Alibardi  L et al.
38
in a  study analyzed  the comparative aspects of 
epidermal keratinisation in vertebrates, with emphasis on the evolution of the 
stratum corneum in land vertebrates .The  Fish epidermis does not contain proteins 
connected with interkeratin matrix and corneous cell envelope formation,  Loose 
keratin filaments are glued together by Mucus-like material . In the case of 
amphibians a cell corneous envelope forms, but matrix proteins, aside from 
mucus/glycoprotein, are scarce or absent while specific proteins associated with 
keratin become relevant for the production of a resistant corneous layer in reptiles, 
birds, and mammals. In reptiles some matrix, histidine-rich and sulfur-rich 
corneous cell envelope proteins are produced in the soft epidermis. In avian soft 
epidermis low levels of matrix and cornified proteins are present while lipids 
become abundant. 
In mammalian keratinocytes, inter-keratin proteins, cornified cell envelope 
proteins, and transglutaminase are present. Topographically localized areas of 
dermal-epidermal interactions in amniote skin determine the formation of skin 
derivatives such as scales, feathers, and hairs. New types of keratin and associated 
proteins are produced in these derivatives. In reptiles and birds, beta-keratins form 
the hard corneous material of scales, claws, beaks, and feathers. Small sulfur-rich 
and glycine-tyrosine-rich proteins form the corneous material of hairs, horns, 
hooves, and claws in mammals. Molecular studies on reptilian beta-keratins show 
they are glycine-rich proteins. They have C- and N-terminal amino acid regions 
homologous to those of mammalian proteins and a central core with homology to 
avian scale/feather keratins
.8,38
 These findings suggest that ancient reptiles already 
possessed some common genes that later diversified to produce some keratin-
associated protein in extant reptiles and birds, and others in mammals. The 
evolution of these small proteins represents the more recent variation of the 
process of cornification in vertebrates 
38
      
Loricrin 
Loricrin is a insoluble polypeptide with a conserved epitope and is a late 
differentiation marker  protein that is introduced into the scaffold of the cornified 
envelope by virtue of its cross linking and binding property  and enhances the 
property of protective barrier of the corneocyte. 
 Loricrin as  a  major  component  of CE. 
The process of terminal differentiation in stratified squamous epithelia such 
as the epidermis, leads to a 15-nm thick layer of protein being deposited on the 
intra-cellular surface of the cell periphery. Steinert PM  and Marekov LN  in their 
study show that this cornified cell envelope (CE) plays a critical role in barrier 
function of the tissue and for the organism and is made up of a complex amalgam 
of proteins cross-linked by isodipeptide bonds formed by the action of 
transglutaminases, like involucrin, cystatin α, several Small proline-rich proteins 
(SPR1, SPR2, in epidermis as well as SPR3 in cultured keratinocytes) loricrin and 
possibly trichohyalin, Filaggrin, Keratin intermediate filaments (KIF)), and a 
putative cysteine-rich protein  that may be elafin and  is regulated by a rise in intra 
cellular calcium.
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The presence of loricrin as a structural protein and a major component of 
the cornified epithelium was illustrated by using the indirect mathematical 
modelling method, and has been estimated that loricrin is the major component 
70%, followed by filaggrin 8%, elafin 6%, small proline rich proteins (SPRs) and 
cystatin α 5% each, and involucrin and keratin intermediate filaments about 2% 
each. This large amount of loricrin is consistent with the abundance of its mRNA 
in the epidermis and has been done by Western blotting or other biochemical 
techniques. Transgenic experiments suggested that loricrin is one of the last 
components added during CE assembly by addition to a pre-existing scaffold of 
proteins such as involucrin and cystatin α.Proteins  pancornulins and involucrin 
were found to be components  released on treating isolated CE’s of cultured 
epidermal keratinocytes with chemical solvents for protein characterization. 
Alternatively after the digestion of isolated CE’s from human foreskin 
epidermis to their constituent amino acids with low specificity proteases the 
remaining insoluble CE remnants were subjected to the mathematical modelling to 
estimate the presence of proteins present, after initial digestion with the trypsin and 
proteinase K digestion. This was followed by immunogold electron microscopy of 
the remnants using a series of monospecific antibodies which removed primarily 
keratin and Filaggrin epitopes from one side of the CEs. During 24 h of digestion 
with proteinase K, only loricrin, SPR, and the novel protein elafin were removed 
primarily, based on both amino acid composition and immunogold criteria.
40
  
From the following experiments it was seen that the outer (cytoplasmic 
surface) third of the CE consists mostly of loricrin/SPRs/Filaggrin; the middle 
third consists of elafin/loricrin/SPRs; and the innermost third adjacent or attached 
to the lipid envelope consists of involucrin and cystatin α and perhaps other as yet 
unknown proteins. Also the keratin intermediate filaments (KIF)  may be buried 
throughout the CE However, the most rigorous evidence for the involvement of a 
protein in CE structure, that circumvents the concerns of degraded, loosely-
associated, or contaminating solubilised proteins, would be to demonstrate 
identifiable protein sequences directly adjoined by isodipeptide cross-links in 
isolated CEs, as has been done in preliminary experiments for Loricrin, proving 
that. Peptides from the outer (cytoplasmic) third of CE structure are mostly 
Loricrin and SPRs.
40
  
In vivo, loricrin is expressed in all mammalian stratified epithelia tested so 
far. However, the highest levels of expression are found in humid tissues such as 
newborn epidermis, the epithelia of oral and anal mucosa, oesophagus, foreskin, 
vagina and the epidermal parts of sweat ducts.
 41 ,42
 
 
Structure of loricrin 
 
According to Yoneda et al 
43
 Loricrin is the major protein component of the 
cornified cell envelope of terminally differentiated mammalian epidermal (stratum 
corneum) cells. Isolation and characterization of the human loricrin gene by using 
a specific human cDNA clone was done. Loricrin was found to  have a very simple 
structure of a single intron of 1188 base pairs (bp) in the 5'-untranslated region 
with  no introns in coding sequences. Loricrin a single copy gene was localized to 
the chromosome 1q21
41,8  
by using rodent-human somatic cell hybrids, followed by 
in situ hybridization with a biotin-labelled genomic DNA clone.
42 
Genomic DNA analysis using PCR (Polymerase chain reaction) from 
different individuals showed  that human loricrin consists of two allelic size 
variants, which is due to sequence variations in its second glycine loop domain, 
and these variants segregate in the human population by normal Mendelian 
mechanisms. Multiple sequence variants  are seen within these two size class 
alleles due to various deletions of 12 basepairs (4 amino acids) in the major loop of 
this glycine loop domain. By use of a specific loricrin antibody, and immunogold 
electron microscopy it is seen that  loricrin initially appears in the granular layer of 
human epidermis and forms composite keratohyalin granules with profilaggrin, but 
localizes to the cell periphery (cell envelope) of fully differentiated stratum 
corneum cells.
43
  
Schmuth  M  et al , 
44
in their study  showed  that  Loricrin which  is a 
glycine–serine–cystine-rich structural protein synthesized in the stratum 
granulosum (SG) layer, migrates to the cell periphery, the outermost layer of the  
SG.  It is then deposited beneath the plasma membrane, cross-linked to several 
other cytosolic proteins  like involucrin, small proline rich proteins (SPRR), elafin, 
repetin, S100, and up to 20 other proteins by means of  transglutaminase-1, 
forming the cornified envelope (CE) contributing to its mechanical resistance. 
The CE not only protects against external injury, but also serves as scaffold 
for the deposition of the extracellular lamellar bilayers which are in turn linked to 
the CE through an interposed layer of covalently bound -hydroxyceramides, the 
cornified-bound lipid envelope (CLE).
44
 
 
  The extracellular lamellar membranes comprised mainly of cholesterol,  
free fatty acids, and ceramides  seal the extracellular spaces against excess, 
bidirectional  movement  of  water, electrolytes, and xenobiotes. The extracellular 
lamellae  is derived from the secretion of lamellar body (LB) contents at the SG–
stratum corneum (SC) interface by a process that occurs immediately prior to 
loricrin cross-linking into the CE . The combination of a hydrophobic extracellular 
compartment, linked to a mechanically resistant protein scaffold, not only provides 
an effective interface between the body and the environment but it also mediates 
additional, protective cutaneous functions, such as antimicrobial, antioxidant, 
chemical, and mechanical defence.
32
  
In the initial stage, involucrin an CE constituent along with the desmosomal 
proteins such as envoplakin and periplakin  forms a “scaffold” by cross-linking to 
produce a monomolecular layer beneath the plasma membrane. Subsequently, 
cross-linking of involucrin occurs with ceramide which replaces the lipid bilayer at 
the plasma membrane leading to the fixation of the scaffold proteins at the cell 
periphery. This scaffold serves as a platform for the subsequent addition of various 
reinforcement proteins, including loricrin and SPRs. These structural proteins, 
before translocation to the cell periphery, are cross-linked to form homo- and 
hetero dimers. In the final dead cornified cells, the completed structure is stabilized 
by a covalent attachment of keratin intermediate filaments to the CE. Among the 
proteins that participated in CE formation, the major substrate molecules are 
involucrin, loricrin and SPR. These proteins have structural properties of 
glutamine- and lysine-rich residues that are commonly modified by 
transglutaminases . (CE- Precursor proteins)
32,33
 
Name Gene locus Size (kDa) 
Human 
foreskin site 
Identified  in 
vivo 
Involucrin 1q21 (EDC)65 2-5% 
Yes 
 
Loricrin 1q21 (EDC) 26 80% 
Yes 
 
SPRs 1q21 (EDC) 6-26 3-5% 
Yes 
 
     (EDC- Epidermal differentiation protein.) 
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Loricrin, is the most abundant protein comprising about 75% - 80% of the 
total CE protein mass, and is insoluble mainly due to its high glycine content.  
Loricrin has the highest glycine content of any known protein in biology 
37,43
It is 
initially sequestered into loricrin granules with an unique amino acid sequence rich 
in glycine, serine, and cysteine residues. Glutamine- or glutamine/lysine residues 
are also frequently observed. Owing to its high rate of expression and low 
solubility, loricrin forms spherical inclusions, called L-bodies in newborn mouse 
skin, human foreskin and acrosyringium, but it is diffusely distributed in the 
cytoplasm of adult epithelia. 
Functions of loricrin   
In vitro cross-linking experiments using recombinant human loricrin have 
demonstrated that the cross-linked loricrin functions as a major reinforcement 
protein for the CE on the cytoplasmic face of the structure- or internal ‘wet’ 
epithelia. 
While a greater content of loricrin is seen in the epidermal CEs, it  is rather less 
(30-50%) in the CEs of certain internal epithelia such as Oesophagus, palate, 
buccal mucosa and is not expressed in many other internal epithelia . Phorbol 
esters, cell confluence, and Ca2+ induce expression of loricrin presumably through 
signals acting through an AP1 site and  it occurs late during the terminal 
differentiation program of these tissues.
32,36,45,46
  
Expression of loricrin in the epidermis is also regulated with the presence 
of certain   immunoglobulin-like cell –cell adhesion molecule like Nectin that 
plays essential roles in the initial step of formation of adherens junctions and tight 
junctions. Newborn nectin-1-/- pups showed shiny and slightly reddish skin with 
marked reduction in the expression of loricrin, with compensatory elevation in the 
amounts of repetin and small proline rich proteins, to overcome the impaired 
expression of loricrin. However, cornified cells from nectin-1-/- mice were 
sensitive to mechanical stress. Moreover, Ca2+-induced activation of ERK through 
Rap1 and expression of loricrin were reduced in primary cultured nectin-1-/- 
keratinocytes.
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Loricrin and OSMF 
In a study by Li N et al, microarray analysis was done and the mRNA 
changes of 14500 genes in 40 OSF and 4 normal buccal mucosa samples were used 
to identify novel biomarkers of OSF. Five candidate genes with the most 
differential changes were chosen for validation, and the correlation between clinico 
pathologic parameters of 66 OSF patients and the expression of each gene was 
assessed using immunohistochemistry. The microarray analysis showed that 661 
genes were up-regulated (fold value>2) and 129 genes were down-regulated (fold 
value<0.5) in OSF (q<0.01). 
The top three up-regulated genes [Loricrin, Cartilage oligomeric  matrix 
protein(COMP), Cys-X-Cys ligand 9(CXCL9)]with the largest fold changes and 
top two down-regulated genes keratin 19(KRT19), cytochrome P450 3A5(CYP 
3A5)]with the most significantly differential changes in OSF were chosen as 
candidate biomarkers. The expression of Loricrin showed statistically significant 
association with histological grade of OSF, P=0.03 with no detectable expression 
in the normal samples. However, 42 (63.6%) of 66 OSF cases exhibited intensively 
brown staining for Loricrin almost limited to the upper spinous epithelial layer and 
sometimes in the keratinocyte layer. The staining was predominantly in the 
cytoplasm, whereas occasionally both cytoplasmic and nuclear immunoreactivity 
were observed. A significant increase in Loricrin expression was observed in OSF 
lesions in comparison with normal buccal mucosa specimens (NBM) specimens 
with over- expression seen frequently in the patients having the habit of chewing 
areca-nut for more than 4 years. The pilot study thus demonstrates 5 novel genes 
which  might play important roles in the pathogenesis of OSF and can  be 
clinically useful for early detection of OSF.
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Loricrin, acts as a protective barrier to protect from environmental hazards, 
and  is one of the differentiation markers and the major protein of the cornified 
envelope of terminally differentiated keratinocyte . The abundance of Loricrin in 
keratinizing epithelia subject to considerable mechanical stress, such as human 
foreskin epidermis implies that expression of Loricrin is essential for the function 
of these tissues. Obviously, the coarse fibers of areca nut are the key mechanical 
stress to the epithelium of oral mucosa of OSF patients; thus, it is plausible to 
hypothesize to find corresponding increase of Loricrin expression in OSF samples. 
Although Loricrin is normally incorporated into the cornified envelope within 2 
hours of synthesis in the differentiating keratinocyte, the enhanced expression of 
extractable Loricrin (not cornified envelope incorporated) in protein extracts from 
OSF, in this study, indicated that it was a protective  response  of the  oral mucosa 
against the persistent  mechanical irritation of areca nuts.  
Loricrin in OSF was identified to be localized in the upper spinous 
epithelial layer and keratinocyte layer corresponding to its location in keratinizing 
epidermis, which could also provide support for the above mentioned hypothesis. 
A significant difference of Loricrin staining between early stage and moderately 
advanced stage of OSF was found but not between moderately advanced stage and 
advanced stage. Which was reasoned to the limited number (n = 13) of advanced-
stage OSF samples used in the study. Further it was postulated that loricrin could 
be a kind of protein with limited capacity against the persistently mechanical stress 
of areca nut in the advanced stage of OSF lesion as a result of the timing of loricrin 
expression during the development of mouse, when compared to that of the other 
epidermal differentiation markers like K14, K10 a and filaggrin and was  found to  
correspond with human and other mammalian species development. 
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Holbrook et al reported the expression of loricrin at around  7-8 wks gestation  in 
the early intermediate  cell layers of human epidermis.
 48
 Yoneda et al   showed 
that endogenous loricrin was expressed  by E16 in transgenic mice with RT-PCR. 
The histologic localization of loricrin with respect to the specific stages of mouse 
epidermal differentiation is expressed focally with the protein appearing in only a 
few granular cells while not being present in the periderm, very similar to the 
expression in the human foetal skin. The periderm which is the initial protective 
barrier of the developing epidermis, begins to get detatched around the time of  
E18, and the underlying epidermis has  to be strong enough to take up the function 
of a strong barrier. The foetal stratum intermedium and stratum corneum provide a 
strong barrier by forming strong and flexible cell envelopes, strong cytoskeletal 
framework and by being impermeable to water. Loricrin by its property of being 
highly insoluble and by its shear mass helps as a protective barrier.
45
  
Li N, Jian XC et al investigated the expression of loricrin and cytochrome 
P450 3A5 (CYP 3A5) in oral submucous fibrosis (OSF) to evaluate their roles in 
the defending ability of epithelium mucosae. On examining  the specimens of 66 
OSF and 14 normal buccal mucosa samples by immunohistochemistry, for the 
expression of  loricrin they found that loricrin was overexpressed in 42 (63.6%) 
cases of OSF, and showed a significant difference only between the early and 
moderately stages of OSF           (P < 0.05), but no clear difference between 
moderately and advanced stages  (P > 0.05). Protein and mRNA expression of 
loricrin was detected by western blot and reverse transcriptase-PCR  (RT-PCR), 
suggesting  that the loricrin might play a vital role in the change of defending 
ability of epithelium  as well as the pathopoiesis and carcinogenesis of OSF 
49
. 
BE Kim et al, 
50
 in a  study  showed that TNF-α  down  regulates  filaggrin 
and loricrin, and thereby affecting the epidermal barrier in certain skin disorders 
like psoriasis and atopic dermatitis. 
A deficiency of filaggrin and loricrin in lesional and non-lesional psoriasis skin 
was demonstated using real time RT PCR and immunostaining and  showed  a 
similar picture on comparing normal skin and psoriatic skin. A decreased 
expression in the epidermal barrier proteins filaggrin and loricrin was noted  
indicating  that the  skin barrier defect seen in psoriatic conditions, are a result of 
deficiency in the epidermal barrier proteins.  On examining the reason for the 
decreased expression of these barrier proteins it was found to be modulated by an 
increased expression of TNF –α, along with increase in some  anti microbial 
peptides like HMB2 (2-Hydroxy-3-Methylbutanoic Acid) proteins  which is the 
reason for decreased infections in Psoriasis inspite of the skin barrier defect. This 
is not so in conditions like Atopic dermatitis where there is increased expression of 
Th2 cytokines which will inhibit the expression of loricrin and fillaggrin barrier 
proteins altogether   with  no expression of  antibacterial peptides
50
 
 
Loricrin mutation  and   associated  diseases. 
Loricrin, inspite of being the most predominant protein of the cornified 
envelope (CE) in keratinocytes, produces only modest skin phenotypes in case of  
loss or gain of  function in murine models, but insertional mutations resulting  in a 
frame shift in the C-terminal domain of loricrin produces the characteristic 
ichthyosis of loricrin keratoderma in mouse and man . 
The unique heterozygous, insertion mutations in the loricrin gene have been found 
to underlie certain congenital skin abnormalities, the phenotypes of which vary 
considerably. Clinically, these patients can be diagnosed as suffering from an  
“Ichthyotic variant of Vohwinkel's syndrome”, “Progressive symmetric 
erythrokeratoderma,” or “congenital ichthyosiform erythroderma” born as a 
collodion baby. Common clinical features include hyperkeratosis of the palms and 
soles with digital constriction. Histologic characteristics include parakeratotic 
hyperkeratosis with hypergranulosis and nuclear accumulation of mutant loricrin. 
The unique mutations in the glycine-rich domain of the mutant loricrin form 
arginine-rich nuclear localization sequences (NLSs) that disrupt differentiation of 
keratinocytes. This group of unique genodermatoses caused by distinct loricrin 
mutations is collectively termed as loricrin keratoderma (LK).
51
 
The basis for the loricrin keratoderma phenotype, was done by  assessing 
the  epidermal structure and stratum corneum function in a previously genotyped 
human loricrin keratoderma  kindred, which showed an  abnormal corneocyte 
fragility and  basal permeability barrier function but an accelerated repair kinetics. 
Despite fragility, increased water loss occurred predominantly via extracellular 
domains, which could be due to the  disorganized  lamellar bilayers that are  linked 
spatially to discontinuities of the CE. The accelerated barrier recovery was seen  by 
amplified lamellar body secretion, while partial normalization of the CE in the 
outer stratum corneum correlated with persistence of abundant calcium in the 
extracellular spaces (positioned to activate transglutaminase-1).The  results showed  
that the barrier abnormality in loricrin keratoderma is linked to a defective CE 
scaffold, resulting in increased extracellular permeability, which is similar to  
another scaffold disorder  “lamellar ichthyosis”, the only difference being the 
partial normalization of the CE scaffold in the outer stratum corneum  in loricrin 
keratoderma.
44
 
Three types of loricrin mutations have been detected in genomic DNA from five 
loricrin keratoderma families. All three mutations are heterozygous insertion 
mutations of a single nucleotide that result in a frameshift and a common 
downstream delayed termination codon. Immunohistochemisty further 
demonstrated that mutant loricrin was expressed in the loricrin keratoderma 
epidermis. The staining patterns were identical between the two Icthyocytic 
Variant of Vohwinkel syndrome patients and two Progressive symmetric 
erythrokeratoderma patients. The staining was localized in the differentiated 
keratinocytes in a predicted tissue and differentiation dependent manner and was 
detected up to the cornified layer. Our results suggest that detection of the mutant 
loricrin in scraped horny layer by immunoblotting or immunohistochemistry might 
offer simple non-invasive screening tests for loricrin keratoderma.  
Positive results have been elicited on testing these antibodies in a different family 
with Palmo plantar keratoderma (PPK). Subsequent DNA sequencing detected an 
insertion mutation of a single nucleotide in the loricrin gene.
 
As for the patho- mechanisms of dominantly inherited disorders, some are 
explained as dominant negative effects of mutant molecules and  are attributed to 
haploinsufficiency. Although loricrin constitutes about 70% of CE in normal skin,
 
37,40,43 
the  phenotype of  loricrin  null  mice  was  just temporary and lasted only 4–
5 d after birth which suggests that  loricrin keratoderma  is not caused by 
haploinsufficiency of loricrin but by some dominant negative effects of the mutant 
loricrin. The nature of these dominant negative effects remains unknown, but  the 
possibility that the mutant loricrin disrupts assembly of CE is considered 
52,53
 
Because of the frame shift mutations, mutant molecules lack the C-terminal 
glutamine-lysine rich domain essential for cross linking  CE of the LK cornified 
cells and were  immunoreactive to involucrin antibodies, but showed very little 
immunoreactivity to loricrin antibodies. This is contrary to the normal CE that was 
positive to loricrin but negative to involucrin. Wild-type loricrin was detected 
along the CE in the granular cells of loricrin keratoderma, and loricrin epitopes on 
the CE of cornified cells were retrieved by protease digestion of the sections. This 
implies  that normal loricrin is cross linked into CE of loricrin keratoderma, but its 
epitopes are masked by extensive further cross linking with other molecules such 
as involucrin. Involucrin is one of the early constituents of CE with their epitopes 
normally masked when the CE is matured by later cross linking of loricrin and 
other molecules By contrast, involucrin cross linking seems to continue after 
loricrin is cross linked and masks loricrin epitopes in LK. Because mutant loricrin 
is expressed within the nuclei and not associated with cell membranes or CE, it is 
unlikely that the mutant loricrin is cross linked into CE directly interfering with its 
formation. But it could be speculated that mutant loricrin deranges keratinocyte 
terminal differentiation by some other mechanisms.
52
 Nuclear localization of 
mutant loricrin suggests that it exerts dominant negative effects through 
interactions with nuclear proteins and/or nucleic acids. The  Arginine-rich 
sequences of mutant loricrin show homology to a highly basic nuclear protein, 
called  protamines  which interact with DNA on their Arginine clusters. 
Alternatively initial association with nucleoli might indicate a pathologic role of 
the mutant loricrin upon  nucleolar functions. 
In the LK epidermis, nucleoli from the basal to the lower granular layer 
were not apparently different from those in normal skin, but those in the upper 
layer were distinct. There was deposition of mutant loricrin within and around the 
nucleoli. Localization of mutant loricrin in the dense fibrillar component and 
granular component of the cells with a high level of ribosomal biosynthesis 
suggests interaction between mutant loricrin and rRNA or rRNA binding proteins. 
Recent evidence also suggests that nucleolus is a preferred intracellular target for 
apoptotic events. Terminal differentiation of keratinocytes is a typical example of 
programmed cell death . Mutant loricrin might derange the keratinocyte 
differentiation/cell death pathway by affecting nucleolus as a target of apoptotic 
cellular changes, which  explains the  delay of the cell death process in loricrin 
keratoderma epidermis in the stage where nuclear DNA is fragmented 
53
 
Alternatively mutant loricrin might disturb other functions of nucleolus that 
include non ribosomal RNA processing and growth factor signal transduction 
50,51
 
The reason for limited distribution of skin lesions in loricrin keratoderma 
patients despite the generalized expression of the mutant loricrin is obscure at this 
moment. In the non lesional skin mutant loricrin-expressing cells were just one cell 
layer thick and were to cornify in the next cell layer. It might be that, if mutant 
loricrin is expressed in a very late stage of terminal differentiation where nucleolus 
is no more active, the mutant loricrin does not hamper the completion of 
differentiation
.37,52
 
  In the palmo-plantar skin loricrin-expressing cells are several layers thick. 
When the cells start to express mutant loricrin, they still have a long way to go 
with late keratinisation processes that are more likely to be affected. But the reason 
for variation in the extra-palmoplantar lesions in “Progresive symmetric erythro 
keratoderma”  and “Ichthyocytic variant of vohwinkel syndrome”  is obscure.Small 
proteins with molecular mass less than 40–60 kDa can cross the nuclear pore 
complex by diffusion loricrin is a small molecule (26 kDa in human and 38 kDa in 
mouse) and localized in both the cytoplasm and nucleoplasm .The mechanisms for 
nuclear translocation and specific association with nucleolus of mutant loricrin 
remain unknown at present. The sequences of mutant loricrin rich in arginine 
might function as consensus bipartite nuclear localization signals. A nuclear 
localization signal or sequence (NLS) is an amino acid sequence which 'tags' a 
protein for import into the cell nucleus by nuclear transport. Typically, this signal 
consists of one or more short sequences of positively charged lysines or arginines 
exposed on the protein surface. Different nuclear localized proteins may share the 
same  nuclear localization signal (NLS).A pepta-peptide  (RRQRR), which has 
been implicated as part of a nucleolar targeting element in signal recognition 
particles , is present in the mutant loricrin and this might be functional. These 
possibilities have to be tested in future studies.
37
 
 Given the various consequential implications  of the mutation in loricrin in  skin 
conditions like loricrin keratoderma , this could be correlated with the condition of 
OSF and other conditions exhibiting hyperkeratosis like leukoplakia wherein the 
expression of this loricrin in a mutant form could be appreciated using 
immunohistochemistry and could result in a proper evaluation of the diseased state. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
PATIENT CHARACTERISTICS:  
 
The study population consisted of (n= 73) cases taken from archival blocks, 
They were segregated into three groups with Group I (n=11) comprising of 
clinically normal appearing mucosa specimen samples, Group –II  comprising of  
(n= 32) Hyperkeratosis samples [Frictional keratosis(n=21) and epithelial 
dysplastic lesions (n=11) ] and Group III comprised of  (n=30)  oral submucous 
fibrosis (OSF) specimen samples. 
SITE:  
All the samples were archival blocks with tissues taken from  buccal 
mucosa. Of the these samples, 5 samples were taken from the retromolar region(1 
case was grouped under Group II, and 4 cases under Group-I) and 1 sample was 
taken  from the right lateral border of tongue. ( grouped under Group-II). The 
samples were evaluated for the expression of loricrin and any staining was 
considered positive. 
GENDER DISTRIBUTION: 
The samples were predominantly taken from male patients with the 81.8% 
of the patients being male in the normal mucosa samples, 93.8% and 86.7% 
respectively in hyperkeratosis and OSF samples. The female population among the 
study groups were distributed as 11.0%, 6.3% and 13.3% respectively in groups I, 
II and III. The P value 0.475 showed that there was no significant relation between 
gender and the study groups.(Table-1;Graph-1) 
STAINING POSITIVITY: 
Overall distribution of positive loricrin expression among the three groups. 
Histopathological evaluation of anti bodies directed against loricrin revealed 
positivity in all three groups. 
Group I Normal mucosa ( n=11)showed negative staining in all the samples except 
2 cases. ie.( n=9) 81.8% stained negative, while  (n= 2) 18.2% showed mild 
positivity. 
Group II  Hyperkeratosis ( n= 32 ), showed positive staining in  n= 27 with 84.4% 
and  n=5 stained  negative with 15.6%. 
Group III  OSF specimens , 66.7% (n = 20) showed positive staining and 33.3%.  
(n=10) showed negative staining. The P value 0.000 showed that there was a 
statistically significant relation between the positive expression of loricrin and the 
study groups. (Table-2; Graph-2) 
STAINING INTENSITY: 
Distribution of staining index of loricrin among the 3 groups were analysed 
and the intensity of staining was graded as  nil, mild, moderate and intense . 
Normal mucosa showed a greater percentage 81.8% (n=9) of negative expression. 
While those cases which showed positivity were of mild intensity and comprised 
of about 11.0% (n=2). 
Hyperkeratosis cases revealed a majority of the cases taking up staining with 
25.0% ( n=8) taking mild stains, 43.8% (n=14)  taking up moderate stains and 
15.6% (n=5) taking  up intense staining. 15.6% (n=5) did not take up any stains . 
Among OSF samples,33.3% (n=10) of the cases had not taken up staining. Mild 
and intense staining were appreciable equally with 16.7% (n=5) of the cases. 
Moderate staining is seen in about 33.3%.( n=10). P- value is 0.006 and is 
significantly higher on comparing the distribution of staining index of loricrin 
among the three groups. (Table-3; Graph-3) 
Distribution of staining index in the stratum spinosum 
The staining index in three stratas of epithelium namely stratum spinosum, 
stratum granulosum and stratum corneum was analysed. 
Normal mucosa and hyperkeratosis samples did not show any staining in their 
stratum spinosal layer. However the stratum spinosum in the OSF samples showed 
different gradations of staining intensities with no staining shown by 83.3% (n=25) 
cases, while mild and intense staining was observed in equal number of cases n=2 
each with 16.7%. (n=3) 33.3% of the cases showed  moderate staining. The results 
were not statistically significant (P=0.261) (Table 4;Graph-4) 
Distribution of staining index in the stratum granulosum 
On comparing the degrees of  staining taken up by the stratum granulosum 
in the three groups, Normal mucosa specimens showed only a mild positive 
staining, taken up by one case n= 1 (9.1%). Hyperkeratotic specimens showed the 
most staining in this layer, while  n =5 (15.6%) cases of the 32 samples showed no 
positivity, n=8 (25.0%), n=14 (43.8%) and n=5 (15.6%)cases showed mild, 
moderate and intense staining respectively. OSF on the other hand had 12 cases 
which did not take up staining in this layer, but showed an increase in the number 
of cases exhibiting an  intense staining reaction in n= 5 (16.7%) cases. Moderate 
staining was seen in 9 (30.0%) followed by mild staining in n=4 (13.3%) of the 
cases. The P value of 0.002 is found to be statistically significant on comparison of 
the staining intensity evaluated in stratum granulosum among the three groups. The 
difference was statistically significant (P = 0.002) (Table 5; Graph 5)  
 Distribution of staining index in the stratum Corneum 
No staining was observed in the case of normal mucosa. Hyperkeratosis 
specimens shows no staining in n=28 (87.5%)cases while moderate and intense 
staining were exhibited by 2 cases each with a percentage of 6.3%. Of the OSF 
specimens n= 26 (86.7%) cases showed no staining in the stratum corneum with 
n=1(3.3%) each showing mild and intense staining. Moderate staining was seen in 
2 cases giving a percentage of n=2  6.7%. the difference was not statistically 
significant (P =0.786)(Table 6; Graph 6) 
 
Distribution of habits among the three groups. 
Assessment of the presence of habit history (chewing, smoking and 
drinking) revealed that, out of the total 73 cases in group I ,II and  III , 55 had 
habits and  18 had no habits. 
In Group I (Normal mucosa) one (n=1; 9.1%) person had habit history and ten (n= 
10; 90.9%) others had no habits. while in Group II  (Hyperkeratosis) twenty six 
(n=26; 81.3%) were to found to have habits : and six (n=6; 18.8%)  had no habits. 
In Group III  OSF 28 (93.3%) had habits and 2 (6.7%) had no habits. 
Among the groups OSF shows the maximum percentage of 50.9% of patients 
having a habit history followed by hyperkeratosis with 47.3%  and normal mucosa  
(1.8%).The difference among the groups were statistically significant.(p = 0.000) 
(Table-7 ;Graph-7) 
 
 
 
Distribution of chewing habit among the groups. 
Analyzing  the distribution of chewing habit alone among the groups that it 
was seen in only one case among the normal mucosa specimens. However 25 cases 
out of the 32  hyperkeratosis specimens had the habit of chewing giving a 
percentage of 78.1%.In  the OSF group, 28 cases ( 93.3 %) had the habit of 
chewing. The difference was statistically significant. 
(P = 0.000)( Table 8 ; Graph 8)  
 
Comparing habit of chewing within the groups 
Within the groups the habit was predominantly seen  in OSF with about 
51.9% (n= 28) of them  having  the chewing habit. 25 hyperkeratosis  cases 
(46.3%) had the habit when comparing it with normal mucosa showed only 
1(1.9%) case with  the habit of chewing. The habit of chewing among groups was 
statistically significant (p =0.000)(Table-9 ; Graph 9) 
Comparing positive loricrin expression within hyperkeratosis. 
On comparing the positivity of loricrin expression within the 
hyperkeratosis group, the physically induced hyperkeratosis group showed 90.5% 
(n=19) positivity while the chemically induced group showed 72.7% (n=8) of cases 
with positive loricrin expression. The difference in expression is not statistically 
significant. (P=0.209) Table-10; Graph-10) 
 
Comparison of staining intensity within hyperkeratosis 
Comparison between the different intensities within the hyperkeratosis 
groups showed that the physically induced hyperkeratosis group had n=9 cases 
which showed no staining, n=2 cases (18.2%) showed mild positivity while 
moderate and intense staining was not observed in any cases. The chemically 
induced cases showed n=5 (15.6%) case with no staining and n=8 cases            (25 
.0%) showing mild cases and n=14(43.8%) showed moderate staining and n=5 
cases(15.6%) showed intense staining. The staining intensities were not 
statistically significant. (P=0.563). (The results of kappa analysis was 0.4) 
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TABLE 1 
 
DISTRIBUTION OF GENDER IN THE STUDY GROUPS (n=73) 
 
 
 
GROUPS 
 
 
 
 
 
GENDER 
 
 
 
P 
VALUE 
 
TOTAL 
MALE FEMALE 
 
 
 
 
0.475 
Group-I 
Normal 
mucosa 
n =11 9 (81.8%) 2 (11.0%) 
Group–II 
Hyperkeratosis 
n = 32 30    (93.8%) 2   (6.3%) 
Group-III 
OSF 
n =11 26   (86.7% ) 4   (13.3%) 
 
 
GRAPH 1 
 
DISTRIBUTION OF GENDER IN THE STUDY GROUPS 
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TABLE 2 
DISTRIBUTION OF POSITIVE LORICRIN EXPRESSION IN THE 
STUDY GROUPS (n=73) 
 
* Statistically significant  at 5% level, P<0.05 
 
GRAPH 2 
DISTRIBUTION OF POSITIVE LORICRIN EXPRESSION IN THE 
STUDY GROUPS (N=73) 
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GROUPS 
 
 
 
 
 
POSITIVITY 
 
 
 
P 
VALUE 
 POSITIVE NEGATIVE 
0.000* 
Group-I 
Normal mucosa 
n = 11 2(18.2%) 9(81.8%) 
Group-II 
Hyperkeratosis 
n = 32 27(84.4%) 5(15.6%) 
Group-III 
OSF 
n =30 20(66.7%) 10(33.3%) 
                                                 TABLE 3  
OVERALL DISTRIBUTION OF  THE STAINING INDEX  AMONG THE 
THREE GROUPS 
                      
        
               
                     
GROUP 
 
              
            
          INTENSITY GRADING  
 
 
 
 
     P  
VALUE 
 
 
NIL MILD MODERATE INTENSE 
 
 
 
 
 
 
 
0.006 
Group-I 
Normal 
mucosa 
n =11 
9(81.8%) 
 
2 (18.2%) 
      0  (0%) 
 
0 (0%) 
 
Group-II 
Hyperke
ratosis 
 
 
n =32 
5 ( 15.6%) 8   (25.0%) 14    (43.8%) 5    (15.6%) 
 
GroupIII 
OSF 
n =30 10(33.3%) 5(16.7%) 10(33.3%) 5(16.7%) 
 
GRAPH 3 
OVERALL  DISTRIBUTION OF  THE STAINING INDEX  AMONG THE 
THREE GROUPS 
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TABLE  4 
 
DISTRIBUTION OF STAINING INDEX IN THE STRATUM  SPINOSUM 
 
 
GRAPH 4 
 
 
DISTRIBUTION OF STAINING INDEX IN THE STRATUM  SPINOSUM 
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GROUPS 
 
              
            
   STRATUM    SPINOSUM 
 
 
 
      P  
VALUE 
 
 
NIL MILD MODERATE 
 
INTENSE 
 
 
 
 
 
 
 
0.261 
Group-I 
Normal 
mucosa 
n =11 
11 
(100.%) 
 
0 (0%) 
 
0  (0%) 
 
 0 (0%) 
Group-II 
Hyperkeratosis 
 
n =32 
32 
(100.%) 
0  (0%) 0    (0%) 0    (0%) 
Group-III 
OSF 
n =30 
25 
(83.3%) 
2(6.7%) 1(3.3%) 2(6.7%) 
TABLE  5 
 
DISTRIBUTION OF STAINING INDEX  IN  STRATUM GRANULOSUM 
 
                      
        
               
                     
GROUPS 
 
              
            
   STRATUM    GRANULOSUM 
 
 
 
     P  
VALUE 
 
 
NIL MILD MODERATE INTENSE 
 
 
 
 
 
 
0.002* 
Group-I 
Normal mucosa 
n =11 9(81.2%) 
 
2(18.2%) 0  (0%) 
 
0 (0%) 
Group-II 
Hyperkeratosis 
 
n=32 
5(15.6%) 8(25.0%) 14(43.8%) 5(15.6%) 
Group-III 
OSF 
 
 
n =30 12(40.0%) 4(13.3%) 9(30.0%) 5(16.7%) 
* Statistically significant  at 5% level, P<0.05 
                                            
 
        
GRAPH 5 
DISTRIBUTION OF STAINING INDEX  IN THE  STRATUM  
GRANULOSUM 
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TABLE  6 
 
DISTRIBUTION OF STAINING INDEX IN THE STRATUM CORNEUM 
                      
        
               
                     
GROUPS 
 
              
            
   STRATUM    CORNEUM 
 
 
 
    P 
VALUE 
 
 
NIL MILD MODERATE INTENSE 
 
 
 
 
 
0.786 
Group-I 
Normal  
mucosa 
 
 
n =11  
11(100.0%) 
 
0  (0%)     0  (0%) 0 (0%) 
Group-II 
Hyperkeratosis 
 
 
n =32 28(87.6%) 0  (0%)   2  (6.2%) 2    (6.2%) 
 
Group-III 
OSF 
 
 
n =30 
26(86.7%) 1(3.3%) 
 
2(6.7%) 
 
1(3.3%) 
 
 
 
 
GRAPH  6 
DISTRIBUTION OF STAINING INDEX IN THE STRATUM CORNEUM 
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 TABLE  7 
 
DISTRIBUTION OF HABITS AMONG THE THREE GROUPS 
 
                      
        
               
             GROUPS 
 
 
 
              
            
             HABITS 
 
 
 
   P 
VALUE 
 PRESENT ABSENT  
 
 
 
 
0 .000* 
Group-I 
Normal mucosa  
n =11 1(9.1%) 10(90.9%) 
GroupII 
Hyperkeratosis 
n = 32 26(81.3%) 6(18.8%) 
Group-III 
OSF 
n = 30 28(93.3%) 2(6.7%) 
* Statistically significant  at 5% level, P<0.05 
 
 
 
 
GRAPH  7 
 
DISTRIBUTION OF HABITS AMONG THE THREE GROUPS 
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TABLE  8 
 
DISTRIBUTION  OF CHEWING HABIT IN  EACH GROUP. 
 
 
* Statistically significant  at 5% level, P<0.05 
 
 
 
GRAPH  8 
 
DISTRIBUTION  OF  CHEWING HABIT IN  EACH GROUP. 
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             GROUPS 
 
 
 
              
            
  CHEWING    HABIT 
P 
VALUE 
 PRESENT ABSENT  
 
 
 
0.000* 
Group-I 
Normal 
mucosa  
n =11 
1(9.1%) 10(90.9%) 
Group-II 
Hyperkeratosis 
n = 32 
25(78.1%) 7(21.9%) 
Group-III 
OSF 
n = 30 
28(93.3%) 2(6.7%) 
 TABLE 9 
 
 
DISTRIBUTION OF FREQUENCY WITHIN THE CHEWING HABIT  IN  THE 
GROUPS 
 
 
 
 
GROUPS 
 
 
 
 
 
CHEWING HABIT 
P 
VALUE 
 PRESENT ABSENT  
 
 
 
0.000* 
Group-I 
Normal mucosa 
n =11 1(1.9%) 10(52.6%) 
Group-II 
Hyperkeratosis 
n =32 25(46.3%) 7(36.8%) 
Group-III OSF 
 
n = 30 28(51.9%) 2(10.5%) 
* Statistically significant  at 5% level, P<0.05 
 
 
 
GRAPH  9 
 
DISTRIBUTION OF FREQUENCY WITHIN THE CHEWING HABIT  IN  THE 
GROUPS 
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 TABLE-10 
 
 DISTRIBUTION OF POSITIVE LORICRIN EXPRESSION WITHIN THE 
HYPERKERATOSIS GROUP. 
 
 
 
 
 
 
GRAPH-10 
 
DISTRIBUTION OF POSITIVE LORICRIN EXPRESSION WITHIN THE 
HYPERKERATOSIS GROUP. 
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             GROUPS 
 
 
 
              
            
             POSITIVITY 
 
 
 
      P 
VALUE 
 
HYPERKERATOSIS POSITIVE NEGATIVE  
 
 
      
      0.209 
 
PHYSICALL
Y INDUCED  
n = 21 
 
19(90.5%) 
 
 
2(9.5%) 
 
 
CHEMICALL
Y INDUCED n = 11 
 
8(72.7%) 
 
3(27.3%) 
  
TABLE-11 
 
 
DISTRIBUTION OF STAINING INDEX WITHIN HYPERKERATOSIS 
 
                      
        
            
HYPERKERATOSIS                
 
              
            
             INTENSITY GRADING  
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0.563 
PHYSICAL INDUCED 
 
 
9(81.8%) 
 
2 (18.2%) 
      
       0  (0%) 
 
0 (0%) 
CHEMICAL INDUCED 
 
5 (15.6%) 8   (25.0%) 14    (43.8%) 5    (15.6%) 
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Fig.1 
 
 
 
 
 
Fig 2: 
 Fig 3: Primary Antibody 
 
 
 
 
 
Fig 4: Secondary antibody 
 
 Fig 5: Hyperkeratosis; Haematoxylin and Eosin staining; (X10 ) 
 
 
 
 
Fig 6: Hyperkeratosis; Haematoxylin and Eosin staining; (X 40 ) 
 
 Fig 7: Hyperkeratosis  without epithelial dysplasia showing loricrin  positivity 
in the  stratum granulosum  by IHC (X10) 
 
 
 
Fig 8: Hyperkeratosis without epithelial dysplasia showing loricrin  positivity 
in the stratum granulosum  by IHC (X40) 
 
 Fig 9 :Hyperkeratosis s with epithelial dysplasia showing loricrin positivity in 
the granular layer by IHC (X10) 
 
 
 
Fig 10: Hyperkeratosis  with epithelial dysplasia showing loricrin 
positivity(X40) 
 
  
Fig 11 :Oral submucous fibrosis showing loricrin positivity in the granular 
layer by IHC (X10) 
 
 
Fig 12: Oral submucous fibrosis samples showing loricrin positivity in the 
granular layer by IHC. (X40) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Discussion 
  
The oral mucosa is exposed to a lot of stress, by both physical and chemical 
agents. To establish its integral role as an effective barrier with properties of 
flexibility and selective permeability, the mucosa of the oral cavity has been 
bestowed with specialized components like proteins, intermediate filaments and 
other cytoskeleton components. Loricrin is one such  protein that could play a role 
in the formation of a protective barrier as it is one of the late envelope proteins of 
the cornified cell envelope encoded by genes clustered in the so-called “epidermal 
differentiation complex” on human chromosome 1q21, 42,8and this study was done 
to evaluate the expression of loricrin in hyperkeratosis, oral submucous fibrosis 
cases and  normal mucosa specimens, as the epithelia subjected to stress show an 
increase in the relative amount of these proteins. 
In conditions like OSF or hyperkeratosis, the chemical stimuli or the 
mechanical stress created due to areca nut chewing plus the calcium present in 
slaked lime can be the inciting factor in promoting the differentiation of the 
keratinocytes in non keratinising epithelia with the increased loricrin seen as a 
compensatory mechanism. It has been reported that loricrin is  normally not 
expressed in non keratinising mucosa and other internal epithelia 
55,56,40
and its 
expression  in certain conditions could be a means of providing protection. 
 
Sample standardisation 
The samples collected were standardized for optimisation of the control sample 
with change in the concentration of the antibodies (1:200, 1:500) and the duration 
of the incubation period. Finally the procedures were standardized to a 
concentration of 1:500, and incubated for 1 hour at room temperature. 
In our study it was found that the loricrin had a positive expression in all 
the three groups, (Group I Normal mucosal samples; Group-II hyperkeratosis and 
Group III OSF samples) with the normal mucosal samples showing 18.2% 
positivity, while hyperkeratosis samples showed 84.4% positivity and OSF 
samples showed a positivity of 66.7% and the positivity in all three groups was 
statistically significant (p<0.001). This is similar to the study done by Li N  et al 
49
 
where 63.6% of the OSF cases showed expression of loricrin, however the normal 
mucosal samples  in their study did not show any staining. 
 
Group-I Normal mucosal samples 
Normal mucosal sample analysis in the study revealed that only one case 
had a  habit history of chewing . Two samples showed  mild positivity to loricrin in 
the stratum granulosum (SG)  and  could be attributed  to the reason that biopsy 
had been taken distal to the retro molar region and might  have been subjected to 
friction from the teeth. Katou et al
57
 in his study when comparing expression of 
SPR2 (small proline rich proteins) and loricrin, found that loricrin was not 
expressed in the non keratinized mucosa or in transplanted skin without stratum 
corneum implying the altered presence of the marker as the possible adaptation of 
the keratinocytes to the changing environment of the oral cavity . Studies by Li N 
also showed negative staining among the normal mucosa
47, 49
 
 
Group-II Hyperkeratosis 
The hyperkeratosis group showed predominant number of cases (81.3%) having a 
habit history with chewing being the primary habit in 78.1%. Staining with loricrin 
was positive in both  the stratum granulosum(SG) and stratum corneum(SC), but 
showed no staining in the stratum spinosum. This was in accordance to the study 
by Katou et al where positive staining in both the layers were seen in transplanted 
skin and keratinized mucosa
57
 
Majority of the cases stained positive in the stratum granulosum,with moderate 
staining being predominant among the staining intensities(43.8%).The stratum 
corneum showed  both moderate and intense staining in about 6.2% of the cases. 
We also analyzed the hyperkeratosis group by dividing it into those that could be 
caused by physical or chemical stresses based on the presence of epithelial 
dysplasia found in the histological sections. An increased number of cases in the 
chemically induced group (hyperkeratosis with epithelial dysplasia) had the habit 
of chewing (90.9%),while the physically induced group(hyperkeratosis without 
epithelial dysplasia) had (76.2%) of cases with habit history.
 
The physically 
induced group showed  loricrin positivity in about 90.47% ,while the chemically 
induced group showed  positivity in 72.7% of the cases with both the cases 
staining predominantly in the stratum granulosum. This further compounds the fact 
that continuous  irritation or micro trauma alters the normal signaling mechanisms 
present in the epidermis which are sensitive to the altered barrier /acute barrier 
disruption  and also to varied external humidities. This has been contradicted by 
Selagae EM
58
 et al  in his study where the expression of  loricrin  is unchanged 
after barrier disruption, while a significant change has been observed with regard 
to involucrin another cornified envelope protein. 
 Areca nut is usually taken along with lime and the increased calcium 
concentration further inhibits the barrier recovery process. A simultaneous increase 
in the lamellar body secretion rates are seen when calcium levels surrounding the 
stratum granulosum cells decline in parallel with the barrier disruption. 
36
 
Barrier disruption removes inhibitory lipids and allows influx of calcium and water 
movement into the SC interstices. SCCE, SCTE (kallikrein 7& 5  resp.) are serine 
proteases which regulate desquamation and are restricted by co-localised and co 
secreted protease inhibitors like SLPI(secretory leukocyte protease inhibitor) and 
SKALP(skin derived anti leukocyte protease) Both these proteases contain TGase 
substrate  domains and are cross linked to loricrin residues in the CE  and  are 
minimally expressed in normal epidermis , but are increased in psoriasis and atopic 
conditions following wound healing or any barrier disruption.
55
  
 
 The presence of calcium in the mucosa of betel nut chewers from the calcium 
hydroxide (slaked lime) was confirmed  by  C R Trivedy et al 
59
by doing a von 
kossa staining suggesting its presence both intra and intercellularly.  
 
Group-III OSF 
Oral submucous fibrosis is a chronic insidious disease with an  obscure 
pathogenesis. Areca nut chewing is considered to be a key factor implicated in its 
pathology. In our study the habits were present in 93.3% of the cases in the OSF 
group indicating a strong causal association between the two.  
While there was a 66.7% positivity in loricrin expression, further examination for 
staining  among the different strata within the epithelium of the oral sub mucous 
fibrosis group revealed that the stratum spinosum showed a positive staining in the 
OSF group alone and not in the other two groups. This could be an finding where a 
rearrangement of the cytoskeleton during cell division could lead to abnormalities 
in the cornified envelope which could be responsible for the molecular events that 
occur during the formation of dysplasia and transformation into malignancy.
8,60 
and 
could be related to the decreased cell density in the atrophic epithelium .There is 
further evidence in the decrease of the retinoic acid receptors (RAR). The RARs 
actually suppresses the differentiation of the epithelium and suppresses the effect 
due to increased calcium induction and normally there is no expression of loricrin 
in the presence of retinoic acid.
60 
Mild, moderate and intense staining were 
observed in the stratum spinosum.  
The staining was moderate in majority of the cases which had staining in the 
stratum granulosum though mild and intense staining reactions were observed in 
13.3% and 16.7% of the cases respectively.  This is concurrent with the findings of  
Li N et al 
47
The p-value which  was less than 0.005  was  found to be statistically 
significant when comparing the staining intensity evaluated in stratum granulosum 
among the three groups. Four cases had positive staining in their stratum corneum. 
The evaluation of OSF by histological grading into early intermediate and 
advanced stages was done(data not included) and the expression was compared in 
all three stages, this revealed that an increased expression was seen in the early and 
intermediate stages with the advanced stage showing a decrease in the staining.  
In our study,(data not included) the  area of  greatest concentration of the  
staining(nucleus or cytoplasm) was also observed  which showed 14 cases with 
greater concentration  of the stain in the nucleus ,OSF and physically induced 
hyperkeratosis(hyperkeratosis without dysplasia) samples showed 6 cases each 
while chemically induced hyperkeratosis(with dysplasia) showed two samples 
exhibiting this feature. 
Intra nuclear accumulation of the loricrin in the granular layer has been seen in 
some cases due to the  introduction of potential nuclear targeting motifs in the 
Arginine rich sequences of the mutant c-terminal peptide that lack the normal 
protein. This alters the transglutaminase mediated cross linking of the peptide to 
other loricrin and other components of the CE, leading to changes in its flexibility 
and disruption of CE. 
61
  
Environmental stimuli can stimulate the epidermal keratinocyte and can 
induce the production of inflammatory cytokines and chemo tactic factors in an 
antigen independent fashion this can later lead to production of substances like 
interferon gamma and tumor necrosis alpha. This could also imply that there is a 
fair chance of the habit inducing mechanical stress leading to barrier function 
alteration.
34
 
The directly activated keratinocytes can also influence endogenous or recruited 
immunocompetent cells. Within the groups the habit was predominantly seen in 
OSF with about 51.9% of them having the chewing habit. While 46.3% in the 
hyperkeratosis group and 1.9% among the normal mucosa cases had any history of 
habit. A significant increase in the chewing habit among the groups were seen. 
(P<0.005) 
A strong expression of loricrin has been seen in the majority of the cases in 
the hyperkeratosis and OSF group in our study. The expression has been 
predominantly in the stratum granulosum layer. while a slightly reduced staining is 
seen in the stratum corneum which could be attributed  to 
 Reduced affinity of the antibodies to the epitopes due to 
continued cross linking 
 Loss of epitope due to proteolysisthat occurs concomitantly 
with other differentiation products 
 Masking of the epitope by other cellular components.56 
   A similar finding by Katou F et al
57
 has been done where they found that  
Loricrin was strongly expressed in the SG of normal skin, transplanted skin 
retaining the SC and keratinized oral mucosa while its expression was absent in the 
transplanted skin lacking the SC and in the non-keratinized oral mucosa. 
Upregulation is also seen in orthokeratotic inflammatory skin diseases (e.g. lichen 
planus), with down regulation in parakeratotic inflammatory diseases (e.g. 
psoriasis vulgaris). The reason behind it being that Psoriasis is an hyper 
proliferative disease and the advanced terminal differentiaton products are 
diminished which includes loricrin along with keratins 1,10 and filaggrin.
56
 
Previous in vivo experiments have suggested that the intrinsic properties of each 
type of epithelium are preserved after transplantation to other sites. Proved by 
cultured palate-derived epithelial cells transplanted to gingival mucosa expressed 
the differentiation programme typical of the original donor cultured sole derived 
epidermal cells transplanted to other body sites maintained their original epidermal 
phenotype. However, the transfer in both experiments was performed between 
basically similar environments, i.e. similarity in the transfer sites wet to wet and 
dry to dry surroundings, respectively. The findings of the present study may 
complement those in vivo experiments, in dealing with dry to wet conditions
57
. 
Keratinocytes might alter their properties only under completely different 
conditions.Here the continuous micro trauma provided by the areca nut and other 
ingredients in chewing creates an environment similar to that of the dry regions 
and hence might be an adaptive response leading to its expression. 
Retinoic acid affects the regulation of loricrin which has a similar expression to 
that of  profilaggrin which is specific for different epidermal layers and follows 
expression of K1 and K10. The two methods of regulation could be either direct or 
indirect wherein the regulation of the gene expression is regulated or the 
differentiating process is regulated. Retinoic acid has also been seen to suppress 
the expression of loricrin in vitro and this can overcome the suppression due to 
calcium induction.
60
All these factors and more enlighten us as to the different 
mechanisms that could play a role in the transformation of the mucosa into 
something which has a potential for malignant transformation.  
The present findings with regard to the expression of loricrin support the 
view on the adaptability of the epithelia to the new stimuli and suggest that it could 
be an important prognostic marker for an earlier diagnosis of a malignant 
transformation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Summary and Conclusion 
 
 
 
The aim of the study was to evaluate the expression of loricrin in oral 
submucous fibrosis hyperkeratosis and normal mucosa with the help of 
immunohistochemistry. The  study comprised of a total of 73  archival tissue 
samples and were divided into three  groups-  ten  normal mucosal 
samples,(Group-I);thirty two tissue samples of hyperkeratosis (Group-II) and thirty  
tissue samples of oral submucous fibrosis(Group-III). 
 Normally expression of loricrin is limited to the stratum granulosum of the 
keratinising epithelia of the oral cavity and the epidermis. It is absent or not 
expressed in the non keratinising epithelia or the lining mucosa of the oral 
cavity.    
 In the present study, Loricrin positivity was seen in groups II and III with 
mild staining in group-I 
 The expression of loricrin  among the three stratas of epithelium namely 
stratum spinosum, stratum granulosum and stratum corneum was evaluated 
with the following results- oral submucous fibrosis specimens showed 
positive staining in all  three stratas, hyperkeratosis specimens showed a 
positive expression in both stratum granulosum and stratum corneum 
 The presence of staining being taken up by the stratum spinosum of oral 
submucous fibrosis specimens alone  could be related to three factors 
 Decreased cell density-as seen by the atrophic epithelium 
 Micro trauma related to areca nut chewing 
 Decrease in the number of (RAR) Retinoic acid receptors. 
 Increased expression is seen in the early and intermediate grades of OSF 
than in the advanced stage indicating its expression being directly related to 
the compensatory mechanism kicking in as a early response to the stress at 
the site. 
 Expression is also seen in the hyperkeratosis group  further convincing the 
fact that loricrin’s expression  facilitates a modest level of protection to the 
changing environment. 
 Chewing habit is seen in almost all the patients establishing   the role of 
areca nut chewing as a key etiological factor in the pathogenesis of OSF   
by-inducing stress (both mechanical and chemical). 
 Expression of loricrin thus could be an early indicator of the various 
changes that could take place as a result of the continuous physical stimuli 
and could be a prognostic marker in oral potentially malignant disorders 
like OSF and leukoplakia.  
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 The dissertation topic titled “ Expression of loricrin in hyperkeratosis, 
oral submucous fibrosis and normal mucosa – An Immunohistochemical 
study” submitted by Dr.Nithya S has been approved by the Institutional Review 
Board of Ragas Dental College and Hospital on 26th September 2011. 
 
 
 
Dr.K.Ranganathan     Dr.S.Ramachandran 
Secretary,      Chairman,  
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 ANNEXURE-II 
 
DISSERTATION PROTOCOL 
 
 
         Title of the proposed research project. 
Expression of Loricrin in Oral Submucous Fibrosis, Frictional keratosis 
(Hyperkeratosis) and Normal mucosa 
          
          Name and designation of the principal investigator: 
Dr. Nithya. S 
II Year Postgraduate student 
Department of Oral and Maxillofacial Pathology 
           
          Name of HOD and staff in-charge: 
            Dr. K. Ranganathan, M.D.S, M .S (OHIO) PhD 
            Dr. K. Umadevi, M.D.S 
            Dr. Elizabeth Joshua, M.D.S 
            Dr. T. Rooban, M.D.S 
 
          Department where the project is to be carried out: 
Study will be conducted in Department of Oral & Maxillofacial Pathology, 
Ragas Dental College & Hospital 
 
          Duration of the project: 
One year 
 
          Rationale: 
Loricrin, a major protein of the cornified envelope, is one of the 
differentiation markers of terminally differentiated keratinocytes. 
Abundance of Loricrin in keratinizing epithelium, subjected to considerable 
mechanical stress has led to the assumption that expression of Loricrin is 
essential for the function of these tissues. The coarse fibres of areca nut and 
the continuous friction from occluding teeth are the major causes of 
mechanical stress to the oral mucosa in oral submucous fibrosis and 
frictional keratosis (hyperkeratosis) respectively. Hence, the role of 
Loricrin in oral epithelium needs to be studied in these two lesions. 
 
Hypothesis: 
There is no difference in the expression of Loricrin in the epithelium of oral 
submucous fibrosis, hyperkeratosis and normal mucosa. 
 
Aim: 
To evaluate the expression of Loricrin in the epithelium of Oral submucous 
fibrosis , hyperkeratosis and normal mucosa. 
 
Objectives: 
 To study the expression of Loricrin in Paraffin Embedded tissue specimens 
of  oral submucous fibrosis. 
 To study the expression of Loricrin in Paraffin Embedded tissue specimens 
of frictional keratosis (hyperkeratosis). 
 To study the expression of Loricrin in Paraffin Embedded tissue specimens 
of normal mucosa. 
 To compare the expression of Loricrin in Paraffin Embedded tissue 
specimens of Oral submucous fibrosis, frictional keratosis (hyperkeratosis) and 
normal mucosa. 
Signature of principal investigator                   
Signature of Head of Department 
Remarks of committee: 
Permission granted         YES    NO 
Modifications / conditions 
Materials and methods:  
 Sample: 
Group I  : 10 tissue samples of normal mucosa, to be obtained with   
   patient’s consent from the extraction site of 3rd molar  
   impaction. 
Group II : 32 tissue samples of frictional keratosis (hyperkeratosis) 
Group III : 30 tissue samples of oral Submucous fibrosis  
 
Procedure: 
         Immunohistochemistry in archival samples, formalin fixed Paraffin 
Embedded Specimens. 
 
Statistics to be used: 
 Data analysis, to be done using SPSS (Statistical Package Of Social 
Science) version- 17.0 
 The Intensity of staining with Loricrin between the groups (-,+,++,+++), 
could be analyzed using Chi-square test. 
 
Equipments and chemical reagents needed: 
Microtome 
Autoclave 
Hot air oven 
Slide warmer 
Coupling jars 
Measuring jar 
Weighing machine 
APES coated slides 
Slide carrier 
Aluminium foil 
Micro-pipettes 
Toothed forceps 
Electronic timer 
Beakers 
Rectangular steel tray with glass rods 
Sterile gauze 
Cover-slips 
Light microscope 
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Reagents used: 
1) Conc. HCl 
2) Laxbro soln 
3) APES (3 amino propyl triethoxy silane) 
4) Acetone 
5) Citrate buffer 
6) Phosphate Buffered Saline (PBS) 
7) H2O2   3% 
8) Deionized distilled water 
9) Nuclear Fast Red 
10) Absolute alcohol 
11) Xylene 
Antibodies used: 
1. Primary antibody      – Loricrin Polyclonal Antibody 
2. Secondary antibody   – EXPOSE   Rabbit specific –Horseradish Peroxidase 
3. Chromogen                – DAB-3, 3’- Diamino-Benzidine 
Detailed budget plan: 
Antibodies   – Rs. 55,000 
Laboratory  Reagents   – Rs.  3,000 
Total      – Rs.58,000 
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2. Ning Li, Xinchun Jian, Yanjia Hu, et al. Discovery of Novel Biomarkers in Oral 
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Prevention 2008 ;17:2249-2259. 
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